|
|
||||||||
Molecular Imaging |
1 From the Imaging Sciences Department (X.W., M.J.K.B.) and Muscle Cell Biology Group, Clinical Sciences Centre, Medical Research Council (Q.L.L.), Hammersmith Hospital, Imperial College London, Du Cane Rd, London W12 0NN, England; Imaging Sciences Department, 2nd Hospital, Shanxi Medical University, Taiyuan, China (X.W.); Department of Medical Physics and Bioengineering, Bristol General Hospital, Bristol, England (H.D.L.); Ultrasound Department, PLA General Hospital, Beijing, China (B.D.); and Neuromuscular/ALS Center, Carolinas Medical Center, Charlotte, NC (Q.L.L.). Received May 4, 2004; revision requested July 20; revision received November 15; accepted December 15. M.J.K.B. supported by U.K. Medical Research Council Career Establishment Grant G0100120. Address correspondence to Q.L.L. (e-mail: qi.lu{at}carolinashealthcare.org).
PURPOSE: To compare three commercial microbubble contrast agents (Optison, SonoVue, and Levovist) for their effect on gene delivery in skeletal muscle in conjunction with the use of therapeutic ultrasound.
MATERIALS AND METHODS: The study was approved by the Animal Care and Use Committee. Plasmid DNA (10 µg) encoding green fluorescent protein (GFP) was mixed with microbubbles (or saline control) and injected into the tibialis anterior muscle of mice with and without adjunct ultrasound (1 MHz, 2 W/cm2, 30 seconds, 20% duty cycle). The efficiencies of GFP transgene expression were determined with four experimental conditions: (a) plasmid and saline as control (six mice), (b) plasmid and Optison (six mice), (c) plasmid and SonoVue (four mice), and (d) plasmid and Levovist (air based, four mice). The right legs were exposed to ultrasound, while the left legs were unexposed. Transfection efficiency was assessed by counting the number of GFP-positive fibers. Tissue damage was assessed by measuring the maximal-damage area on serial sections.
RESULTS: When ultrasound was applied, both SonoVue and Optison significantly improved (P < .05) gene transfection efficiency. Optison was also effective (P < .05) even when no ultrasound was applied, which is consistent with previous studies. Levovist without ultrasound decreased the level of transfection (P < .05), with increased tissue damage.
CONCLUSION: Both nonair-based agents show promise in gene delivery in skeletal muscle with undetectable tissue damage. Enhanced gene transfer with additional ultrasound was achieved only with SonoVue.
© RSNA, 2005
This article has been cited by other articles:
![]() |
M. Duvshani-Eshet, O. Benny, A. Morgenstern, and M. Machluf Therapeutic ultrasound facilitates antiangiogenic gene delivery and inhibits prostate tumor growth Mol. Cancer Ther., August 1, 2007; 6(8): 2371 - 2382. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sonoda, K. Tachibana, E. Uchino, A. Okubo, M. Yamamoto, K. Sakoda, T. Hisatomi, K.-H. Sonoda, Y. Negishi, Y. Izumi, et al. Gene Transfer to Corneal Epithelium and Keratocytes Mediated by Ultrasound with Microbubbles Invest. Ophthalmol. Vis. Sci., February 1, 2006; 47(2): 558 - 564. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |